Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 15, 2005 - Issue 7
Submit an article Journal homepage
89
Views
8
CrossRef citations to date
0
Altmetric
Patenting Perspective

The Jean Chrétien Pledge to Africa Act: patent law and humanitarian aid

Matthew Rimmer The Australian National University, ACIPA, Faculty of Law, Canberra, ACT, 0200, Australia. [email protected]
Pages 889-909 | Published online: 13 Jul 2005

Bibliography

  • FAUNCE T, DRAHOS P: Trade related aspects of intellectual property eights (TRIPS) and the threat to patients: a plea to doctors to respond internationally. Med. Law (1998) 17:299.
  • NIELSEN J, NICOL D: Pharmaceutical patents and developing countries: the conundrum of access and incentive. Australian Intellectual Property j (2002) 13:289.
  • Global Intellectual Property Rights: Knowledge, Access and Development. Drahos P, Mayne R (Eds), Palgrave Macmillan, Hampshire (2002).
  • GERVAIS D: The TRIPS Agreement: Drafting History and Analysis (2nd Ed.), Sweet and Maxwell, London, UK (2003).
  • SELL S: Private Power, Public Law: the Globalization of Intellectual Property Rights. Cambridge University Press, Cambridge, UK (2003).
  • OPDERBECK D: Patents, essential medicines, and the innovation game. Vanderbilt Law Rev. in press.
  • MAYNE R: The global campaign on patents and access to medicines: an Oxfam perspective. In: Global Intellectual Property Rights: Knowledge, Access and Development. Drahos P, Mayne R (Eds), Palgrave Macmillan, Hampshire, UK (2002):245.
  • MCGREAL C: South Africa's sick await judgment day. The Guardian Weekly (8–14 March 2001):1.
  • O'LOUGHLIN E: Politicians and drug firms playing with lives. Cynical Squabble Over AIDS. The Sydney Morning Herald (10 March 2001):20–21.
  • O'LOUGHLIN E: New hope on AIDS drugs for the poor. The Sydney Morning Herald (19 April 2001):1.
  • NASH D: South Africa's Medicines and Related Substances Control Amendment Act of 1997. Berkeley Tech. Laz .) J. (2000) 15:485.
  • •Academic commentary.
  • WOOLDRIDGE F: Analysis: affordable medicines - TRIPs and United States policies. Intellectual Property Quarterly (2000):103.
  • BOMBACH K: Can South Africa fight AIDS? Reconciling the South African Medicines and Related Substances Act with TRIPS agreement. Boston Univ. Int. Laz .) (2001) 19(2)273–306.
  • Brazil - measures affecting patent protection. WT/D5199/4, G/L/454, IP/D/23/Add.1 (19 July 2001):01–3506.
  • CHAMP P, ATTARAN A: Patent rights and local working under the WTO TRIPS Agreement: an analysis of the US-Brazil patent dispute. Yak Int. Law. (2002) 27(2):365–393.
  • RESNIK D, DE VILLE K: Bioterrorism and patent rights: 'compulsory licensure' and the case of Cipro. Am. J. Bioethics. (2002) 2(3):29–39.
  • GOLDBERG R: Terrorising Patents. Expert Opin. Ther. Patents (2002) 12(3):329–330.
  • FERRONE J: Compulsory licensing duringpublic health crises: bioterrorism's mark on global pharmaceutical patent protection. Suffolk Transnational Law Rev. (2003) 26:385.
  • WTO Doc WT/MIN (01)/DEC/2 (2001).
  • ABBOTT F: The Doha Declaration on the TRIPS Agreement and Public Health: lighting a dark corner at the WTO. J. Int. Economic Law (2002) 5:469–505.
  • •Academic commentary.
  • GATHII JT: The legal status of the Doha declaration on TRIPS and public health under the Vienna Convention on the Law of Treaties. Harvard J. Law Tech. (2002) 5(2):291–317.
  • MURTHY D: The future of compulsory licensing: deciphering the Doha Declaration on the TRIPS Agreement and public health. Am. Univ. Int. Law Rev. (2002) 17(6):1299–1346.
  • ROTT P: The Doha Declaration - good news for public health. Intellectual Property Quarterly (2003) 3:284–311.
  • ATTARAN A: Assessing and answering paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health: the case for greater flexibility and a non-justiciability solution. Emory Int. Law Rev. (2003) 17:743–780.
  • •Academic commentary
  • MATTHEWS D: WTO decision on implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health: a solution to the access to essential medicines problem? J. Int. Economic Law (2004) 7:73–107.
  • BRAITHWAITE J, DRAHOS P: Global Business Regulation. Cambridge University Press, Cambridge. (2000):15–26.
  • MARTIN P: Prime Minister's statement on amendments to bill C-9, The Jean Chrétien Pledge to Africa Act. Ottawa, Ontario. (20 April 2004).
  • ABBOTT F: Testimony before the Standing Committee on Industry, Science and Technology. House of Commons, 37th Parliament, 3rd Session (10 March 2004).
  • OUTTERSON K: Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets. Yale J. Health Policy Law Ethics (2004) 5:193.
  • Schedule Two; Jean Chrétien Pledge to Africa. Canada (2004).
  • Schedule Three; Jean Chrétien Pledge to Africa. Canada (2004).
  • Schedule Four; Jean Chrétien Pledge to Africa. Canada (2004).
  • WHO: Statement of the World Health Organization on Canada's proposed legislative changes for medicines. Geneva. (7 November 2003).
  • ELLIOTT R: Global Access to Treatment: Canada's Bill C-9 and the compulsory licensing of pharmaceuticals for export to countries in need. Canadian HIV-AIDS Legal Network (July 2004).
  • ELLIOTT R, MEMBERS OF THE GLOBAL ACCESS TREATMENT CAMPAIGN: TRIPS From Doha to Canciin. to Ottawa: WTO patent rules and Canadian civil society advocacy for global treatment access. 15th World AIDS Conference. Bangkok, Thailand. (July 2004).
  • OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE: US and Canada agree to assist poor countries access to medicine. San Antonio, Texas (16 July 2004).
  • WTO PANEL REPORT: WT/D5170/R-Canada-Patent Protection of Pharmaceuticals, complaint by the United States (5 May 2000)
  • WTO PANEL REPORT: WT/DS114/R-Canada-Patent Protection of Pharmaceutical Products complaint by the European Communities and their Member States (17 March 2000).
  • COMMISSION OF THE EUROPEAN COMMUNITIES: Supra note 49.
  • RICHARD ELLIOTT: Supra note 37.
  • Glaxo Group Ltd v. Dowelhurst Ltd (2003) E.W.H.C. 3060 (High Court, Ch. Div. 2003) available at 2003 WI, 23014797.
  • Glaxo Group Ltd v. Dowelhurst Ltd (2004) E.T.M.R. 39 (July 31, 2003) available at 2003 WL 21729286.
  • DAN ISAACS: GSK Aims to Stop Aids Profiteers. BBC News. (21 February 2005).
  • KEVIN OUTTERSON: Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets. Yale Journal Health Policy Law and Ethics (2004) 5:193.
  • France to introduce legislation for generic exports. AFP (22 November 2004).
  • Hearing on TRIPS and Access to Medicines, Committee on International Trade, European Parliament, Brussels (18 January 2005).
  • BAINS P: Hearing on TRIPS and Access to Medicines, Committee on International Trade, European Parliament, Brussels (18 January 2005).
  • HADDAD W: Hearing on TRIPS and Access to Medicines, Committee on International Trade, European Parliament, Brussels, (18 January 2005).
  • 'T HOEN E: Hearing on TRIPS and Access to Medicines, Committee on International Trade, European Parliament, Brussels (18 January 2005).
  • DUTFIELD G: Intellectual Property Rights And The Life Science Industries. Aldershot, Ashgate. (2003):109.
  • GRUEN N, BRUCE I, PRIOR G: Extending Patent Life: Is It In Australia's Economic Interests? Commonwealth Government: Productivity Commission (June 1996).
  • Aktiebolaget Hassle v Alphapharm Pty Ltd (2002) 212 CLR 411.
  • Aktiebolaget Hassle v Alphapharm Pty Ltd (2002) 212 CLR 411 at 449–450.
  • SENATE SELECT COMMITTEE ON THE FREE TRADE AGREEMENT BETWEEN AUSTRALIA AND THE UNITED STATES OF AMERICA: Final Report. Canberra: Australian Parliament (August 2004):137.
  • FRASER A: Fears FTA will stop vital drugs. The Canberra limes (30 June 2004):13.
  • FAUNCE T: Hearing. Senate Select Committee on the Free Trade Agreement Between Australia and the United States of America (21 June 2004):7.
  • LAWSON C, PICKERING C: `TRIPs-Plus' patent privileges - an intellectual property 'Cargo Cult' in Australia. Prometheus. (2004) 22(4):355.
  • DEADY S: Hearing. Senate Select Committee on the Free Trade Agreement Between Australia and the United States of America (21 June 2004):18.
  • STEPHEN DEADY: Hearing. Senate Select Committee on the Free Trade Agreement Between Australia and the United States of America (21 June 2004):53.
  • MARTIN QUINN: Public Hearing. Intellectual property, Senate Select Committee on the United States-Australia Free Trade Agreement (6 July 2004).
  • Senate Select Committee on the Free Trade Agreement between Australia and the United States of America, Final Report. Canberra. Australian Parliament (August 2004):135.
  • AUSTRALIAN LAW REFORM COMMISSION: Gene Patenting and Human Health: Discussion Paper 68, supra note 120 at 731.
  • AUSTRALIAN LAW REFORM COMMISSION: Gene Patenting and Human Health: Discussion Paper 68, supra note 120 at 730.
  • AUSTRALIAN LAW REFORM COMMISSION: Genes and Ingenuity: Gene Patenting and Human Health. Report 99, supra note 120 at 629.
  • AUSTRALIAN LAW REFORM COMMISSION: Genes and Ingenuity: Gene Patenting and Human Health. Report 99, supra note 120 at 630.
  • KANAKO TAKAHARA: Japan urged to take lead in easing of drug patents. Japan Times (14 February 2003).
  • NATH K: Statement on the ordinance relating to patents (Third Amendment). (27 December 2004).
  • India to curb export of cheap copycat generic drugs. AFP (25 December 2004).
  • MEDECINS SANS FRONTIERES: Sources of affordable generic medicines drying up? India should ensure global access to medicines. (15 March 2005).
  • MEDECINS SANS FRONTIERES: The beginning of the end of affordable genetics. (22 March 2005)
  • MEDECINS SANS FRONTIERES: Now that the dust gas settled: the consequences of the new Indian patents act. (29 March 2005).
  • 'T HOEN E: Hearing on TRIPS and access to medicines. Committee on International Trade, European Parliament, Brussels (18 January 2005).
  • KAMPF R: Hearing on TRIPS and access to medicines. Committee on International Trade, European Parliament (18 January 2005).
  • LOVE J, HUBBARD T: Make drugs affordable: replace TRIPS-Plus with R&D. Bridges (2004) 6:3–4
  • RIMMER M: The race to Patent the SARS virus: The TRIPS agreement and access to essential medicines. Melbourne J. Int. Law (October 2004) 5(2):335–374.

Websites

  • http://www.cptech.org/ip/health/sa/ harma v sa Phtml - • Archive of the litigation between the Pharmaceutical Manufacturers' Association of South Africa et al. v. the Government ofSouth Africa.
  • http://www.cptech.org/ip/health/c/brazil/ An archive of documents on the WTO challenge by the US against Brazil.
  • http://www.wto.org/english/tratop_e/ trips_e/implem_para6_e.htm GENERAL COUNCIL: Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health. (1 September 2003) WT/L/540.
  • http://www.wto.org/english/news_e/ news03_e/trips_stat_28aug03_e.htm Statement of General Council Chairperson (13 November 2003) WT/GC/M/82.
  • http://www.indianembassy.org.br/port/ relations/ForumForCo-operation.htm India-Brazil-South Africa Dialogue Forum Trilateral Commission Meeting, New Delhi Agenda for cooperation and plan of action. (5 March 2004).
  • •There has been discussion of a trade bloc being formed between three key developing countries.
  • http://www.awcfs.org/Icasa/DayFive/ StephenLewis4.html LEWIS S: The politics of resource allocation, statement by United Nation Secretary General's Special Envoy on HIV/AIDS. Nairobi, Kenya (25 September 2003).
  • http://www.aidslaw.ca/Maincontendissues/ cts/patent-amend/ TACALP_submission_SCIST.PDF Treatment action campaign, submission on bill C-9 to Canada's Parliamentary Committee. (26 February 2004).
  • http://www.parl.gc.ca/37/3/parlbus/ chambus/house/bills/government/C-9/C-9_2/C-9_cover-E.html Bill C-9. An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chretien Pledge to Africa). Canada (2004).
  • http://www.paulmartin.ca/home/ stories_e.asp?id886 MARTIN P: Confederation Dinner. (9 December 2003).
  • http://www.parl.gc.ca/InfocomDoc/37/3/ INST/Meetings/Evidence/INSTEV02-E.HTM ROBILLARD L: Bill C-9, Standing Committee on Industry, Science and Technology. 37th Parliament, 3rd Session (24 February 2004).
  • http://www.parl.gc.ca/37/3/parlbus/ commbus/senate/com-e/FORE-E/04ev-e.htm?LanguageE&Par137&Ses2&com m_id8 ROBILLARD L: Bill C-9, proceedings of the Standing Committee on Foreign Affairs. 37th Parliament, 3rd Session (12 May 2004).
  • http://www.parl.gc.ca/InfocomDoc/37/3/ INST/Meetings/Evidence/INSTEV02-E.HTM ROBILLARD L: Bill C-9, Standing Committee on Industry, Science and Technology. 37th Parliament, 3rd Session (24 February 2004).
  • http://lists.essential.org/pipermail/ip-health/ 192004-November/007091.html ELLIOTT R: Doha Paragraph 6 Implementation: EU Proposal versus Canadian Legislation. Canadian HIV/AIDS Legal Network (1 November 2004).
  • http://www.parl.gc.ca/37/3/parlbus/ chambus/house/debates/043_2004-04-28/ han043_1540-E.htm MASSE B: Speech on Bill C-9. 37th Parliament, 3rd Session, Hansard, No. 43. (28 April 2004).
  • http://www.aidslaw.ca/Maincontendissues/ cts/patent-amend/ TACALP_submission_SCIST.PDF Treatment Action Campaign: submission on Bill C-9 to Canada's Parliamentary Committee. (26 February 2004).
  • http://www.ftaa-alca.org/FTAADraft03/ Index_e.asp Free Trade Area of the Americas.
  • http://www.doctorswithoutborders.org/ publications/reports/2003/ FTAA Advocacy.pdf Agreement Medecins Sans Frontieres: trading away health: intellectual property and access to medicines in the free trade area of the Americas Agreement (August 2003).
  • http://trade-info.cec.eu.int/doclib/docs/ 2004/october/tradoc_119802.pdf Commission of the European Communities: proposal for a regulation of the European Parliament and Council on Compulsory Licensing of Patents relating to the manufacture of pharmaceutical products for export to countries with public health problems (29 October 2004).
  • http://www.eurunion.org/News/press/ 192004/200400154.htm LAMY P: EU proposes legislation to allow export of generic medicines to poor countries. No. 154/04 (29 October 2004).
  • http://www.eurunion.org/News/press/ 192004/200400154.htm BOLKESTEIN F: EU proposes legislation to allow export of generic medicines to poor countries. No. 154/04 (29 October 2004).
  • http://www.egagenerics.com/pr-2004-11-02.htm EUROPEAN GENERICS MEDICINES ASSOCIATION: New EU regulation on compulsory licensing aims to help countries with important health needs (2 November 2004).
  • http://www.geneva.quno.info/pdf/ DohaImplSeminar0504.pdf HEPBURN J: Implementing the Paragraph 6 Decision and Doha Declaration: solving practical problems to make the system work. Quaker United Nations Office, Jongny-sur-Vevey, Switzerland (21–23 May 2004).
  • http://www.cptech.org/ip/health/c1/ netherlands-export-rules.html For information on the legislation.
  • http://www.evb.ch/ index.cfm?page_id3288 Implementation of WTO Decision on Paragraph 6 of Doha: proposed amendment to Swiss patent law and the comments of the Berne Declaration (21 October 2004).
  • http://www.wto.org/english/thewto_e-dg_e/stat_lamy_e.htm LAMY P: Statement in the WTO Director-General Selection Process. WTO General Council Geneva (26 January 2005).
  • http://www.trademinister.gov.au/releases/ 192003/myt067_03.html VAILE M: Vaile welcomes breakthrough on essential medicines. Department of Foreign Affairs and Trade (31 August 2002).
  • http://www.ausaid.gov.au/publications/pdf/ aids_strategy.pdf Meeting the Challenge: Australia's AIDS Policy (July 2004).
  • http://www.industry.gov.au/assets/ documents/itrinternet/ PharmPapersepOl.pdf HILL J, KIRCHNER A, HOLMES A: Pharmaceuticals industry action agenda: discussion paper (September 2001).
  • http://www.ipta.com.au/notices/ Paten0/020IDC°/020Background°/020Paper-°/020Publicfinall.doc Department of Industry, Tourism and Resources. Discussion aper on patent extensions and springboards. (September 2002).
  • http://www.ftc.gov/os/2002/07/ genericdrugstudy.pdf The Federal Trade Commission has been critical of the operation of the 'Hatch-Waxman Act' in the United States, and has proposed a number of legislative reforms. Federal Trade Commission, Generic Drug Entry Prior to Patent Expiration: An FTC Study (July 2002).
  • http://www.austlii.edu.au/au/other/alrc/ publications/issues/27/ AUSTRALIAN LAW REFORM COMMISSION: Gene Patenting and Human Health: Issues Paper 27. Sydney. Australian Commonwealth (July 2003).
  • http://www.austlii.edu.au/au/other/alrc/ publications/dp/68/ AUSTRALIAN LAW REFORM COMMISSION: Gene Patenting and Human Health: Discussion Paper 68. Sydney. Australian Commonwealth (February 2004).
  • http://www.austlii.edu.au/au/other/alrc/ publications/reports/99/ AUSTRALIAN LAW REFORM COMMISSION: Genes and Ingenuity: Gene Patenting and Human Health. Report 99. Sydney. Australian Commonwealth (June 2004).
  • http://www.ipleft.oar/patent/patent_bill Draft bill for Amending Korean Patent Act introduced in the National Assembly by 15 Congressmen (26 November 2004).
  • •For details on the Korean legislative proposal.
  • http://www.cptech.org/ip/wto/ africagroup11302004.pdf Communication from Nigeria on behalf of the African Group. Implementation of Paragraph 11 of the 30 August Decision.
  • http://www.cptech.org/ip/health/rndtf/ bridges042004.pdf See [74].
  • http://mjil.law.unimelb.edu.au/mjil/issues/ archive/ 192004(2)/02Rimmer.pdf See [75].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.